ELDNEledon Pharmaceuticals, Inc.vs its industry peers
A metric-by-metric comparison of Eledon Pharmaceuticals, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ELDNThis | $215M#6 | — | 6.5x#12 | — | — | -26.1%#11 | — | -138.2%#12 | — | — | 9.1%#2 | — |
| WHWK | $235M#2 | — | 1.3x#6 | 32.9x#6 | -72.5%#6 | 67.7%#5 | -1601.1%#6 | -11.3%#5 | — | — | 110.5%#1 | — |
| NATR | $231M#3 | 13.1x#2 | 1.7x#9 | 0.5x#2 | 5.7%#5 | 153.7%#3 | 5.2%#3 | 14.3%#3 | — | 9#1 | — | — |
| ZNTL | $222M#4 | — | 1.5x#7 | — | -100.0%#7 | 17.4%#7 | — | -95.4%#10 | — | — | — | — |
| KROS | $219M#5 | — | 0.8x#2 | 0.9x#3 | 6775.0%#1 | 146.4%#4 | 27.7%#1 | 33.2%#1 | — | — | -29.1%#3 | — |
| BRVE | $2.6B#1 | — | — | — | — | — | — | — | — | — | — | — |
| NKTX | $204M#7 | — | 0.8x#1 | — | — | 4.3%#9 | — | -42.0%#6 | — | — | — | — |
| PEPG | $201M#8 | — | 1.7x#8 | — | — | 0.4%#10 | — | -75.0%#9 | — | — | — | — |
| ORMP | $196M#9 | 1.1x#1 | 1.0x#4 | 97.8x#7 | — | 573.1%#2 | -754.4%#4 | 0.0%#4 | -4.4%#2 | — | — | — |
| TNXP | $195M#10 | — | 0.9x#3 | 14.9x#4 | 29.8%#3 | 4.6%#8 | -959.1%#5 | -55.8%#8 | -234.8%#4 | — | — | — |
| ANTX | $195M#11 | — | 2.6x#11 | — | — | 31.5%#6 | — | -46.3%#7 | — | — | — | — |
| KRRO | $189M#12 | — | 1.8x#10 | 29.6x#5 | 181.5%#2 | -40.3%#12 | -1906.4%#7 | -113.6%#11 | -155.2%#3 | — | — | — |
| ORGO | $177M#13 | — | 1.2x#5 | 0.3x#1 | 17.0%#4 | 4011.1%#1 | 7.9%#2 | 25.0%#2 | 23.2%#1 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice